What question did this study set out to answer?

To examine and clarify the scientific evidence and methodological divergence that led to contrasting carcinogenicity conclusions regarding glyphosate between IARC and EFSA.

March 3, 2016Journal of Epidemiology & Community HealthOpen Access

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA)

View Full Paper

Ask AI

Bookmark

To examine and clarify the scientific evidence and methodological divergence that led to contrasting carcinogenicity conclusions regarding glyphosate between IARC and EFSA.
Comparative toxicological and epidemiological assessment contrasting the evaluation frameworks of the International Agency for Research on Cancer and the European Food Safety Authority.
Review of published peer-reviewed literature alongside proprietary industry submissions covering rodent bioassays, genotoxicity mechanisms, and human epidemiological studies.
Divergent classifications stemmed primarily from EFSA's reliance on non-peer-reviewed, unpublished industry studies, contrasting with IARC's protocol requiring published, transparent, and verifiable scientific data.
Methodological discrepancies in statistical evaluation of rodent carcinogenicity assays led IARC to identify significant dose-response increases in rare tumors, including renal tubule carcinomas and hemangiosarcomas, which EFSA dismissed.
Differences in the evidentiary weighting of genotoxicity and oxidative stress pathways substantially drove the split between EFSA's non-carcinogenic designation and IARC's classification as probably carcinogenic to humans.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Comparative review reveals conflicting carcinogenic evaluations of glyphosate across regulatory bodies, highlighting divergent interpretations of toxicological and epidemiological evidence.

Cite This Study

Portier et al. (2016) studied this question.

synapsesocial.com/papers/6a7d4b23e9cd826fb346d175 https://doi.org/10.1136/jech-2015-207005

View Full Paper

Ask AI

Bookmark

Implication

Comparative review reveals conflicting carcinogenic evaluations of glyphosate across regulatory bodies, highlighting divergent interpretations of toxicological and epidemiological evidence.

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA)

Key Points

Discussion

Implication

Cite This Study

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA)

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider